跳转至内容
Merck
CN

719935

聚(D,L-乳酸)

ester terminated, Mw 18,000-28,000

别名:

RESOMER® R 203 S, PDLLA, 乳酸聚合物

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
[C3H4O2]x[C2H2O2]y
化学文摘社编号:
MDL number:
UNSPSC Code:
12162002
NACRES:
NA.23
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

[H]OC(C(OC(C(O[R])=O)C)=O)C

InChI

1S/C6H8O4.C4H4O4/c1-3-5(7)10-4(2)6(8)9-3;5-3-1-7-4(6)2-8-3/h3-4H,1-2H3;1-2H2

InChI key

LCSKNASZPVZHEG-UHFFFAOYSA-N

form

amorphous

mol wt

Mw 18,000-28,000

degradation timeframe

<6 months

viscosity

0.25-0.35 dL/g, 0.1 % (w/v) in chloroform(25 °C, Ubbelohde) (size 0c glass capillary viscometer)

transition temp

Tg 46-50 °C

storage temp.

2-8°C

Quality Level

General description

Ester terminated Poly(D,L-lactide) (PDLLA, RESOMER® ) is a copolymer of L and D-lactic acid and (or L and D lactide). The structure is highly irregular and amorphous. RESOMER® polymers are bioresorbable aliphatic polyesters comprised of a range of different ratios of lactide and glycolide monomers, PLA stereochemistries, and end-group functionalization.

Application

控释

Legal Information

Evonik产品
RESOMER is a registered trademark of Evonik Rohm GmbH

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Auras RA, et al.
Poly(lactic acid): Synthesis, Structures, Properties, Processing, and Application null
Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies.
Lemmouchi Y, et al.
Biomaterials, 19(20), 1827-1837 (1998)

商品

In the past two decades, tissue engineering and regenerative medicine have become important interdisciplinary fields that span biology, chemistry, engineering, and medicine.

AliAliphatic polyesters, including polylactide and polyglycolide, are biodegradable polymers widely used in medical applications.

Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.

Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持